Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.

Abstract

Several guidelines are available to guide the initiation of highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV)-infected children. The recommendations in these guidelines show significant variability. Because there is no well-established evidence on when to start HAART, it is left to the discretion of the pediatrician which… (More)

Topics

Cite this paper

@article{Verweel2006InitiatingHA, title={Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.}, author={Gwenda Verweel and Jes{\'u}s Saavedra-Lozano and Annemarie M. C. van Rossum and Octavio Ramilo and Ronald de Groot}, journal={The Pediatric infectious disease journal}, year={2006}, volume={25 11}, pages={987-94} }